AtriCure (ATRC) Invested Capital (2010 - 2024)

AtriCure (ATRC) has 14 years of Invested Capital data on file, last reported at $2.8 million in Q4 2024.

• On a quarterly basis, Invested Capital fell 69.33% year-over-year to $2.8 million in Q4 2024; TTM through Sep 2025 was $2.8 million, a 69.33% decrease from a year earlier, with the FY2024 full-year figure at $2.8 million, down 69.33% from the prior year.
• Invested Capital for Q4 2024 stood at $2.8 million, down from $9.1 million in the prior quarter.
• Over the last five years, Invested Capital for ATRC reached as high as $11.8 million in Q4 2020 and fell as low as $2.8 million in Q4 2024.
• Historically, Invested Capital has averaged $9.7 million across 5 years, with a median of $10.3 million in 2022.
• Across the five-year window, Invested Capital decreased 6.91% in 2021 and sank 69.33% in 2024, its largest moves.
• Year by year, Invested Capital stood at $11.8 million in 2020, then retreated by 6.91% to $11.0 million in 2021, then dropped by 7.63% to $10.1 million in 2022, then retreated by 9.78% to $9.1 million in 2023, then sank by 69.33% to $2.8 million in 2024.
• Per Business Quant data, the three most recent Invested Capital figures were $2.8 million in Q4 2024, $9.1 million in Q4 2023, and $9.4 million in Q3 2023.